World Heart Federation Roadmap for Heart Failure
João Pedro Ferreira(Inserm), Karen Sliwa(University of Cape Town), Sharon Mitchell(World Heart Federation), John J.V. McMurray(Western Infirmary), Mahmoud U. Sani(Aminu Kano Teaching Hospital), Rudolf A. de Boer(University Medical Center Groningen), Clyde W. Yancy, Faı̈ez Zannad(Inserm), Ileana L. Piña(Inserm), Mary Norine Walsh(St Vincent Hospital), Sarah Kraus(University of Cape Town), Hugo Grancelli(Hospital de Niños de la Santísima Trinidad), Ovidiu Chioncel, Carolyn S.P. Lam, Juan Esteban Gómez‐Mesa(Inserm), Alexandre Mebazaa, Pablo Perel(London School of Hygiene & Tropical Medicine), Gurusher Panjrath(George Washington University), Daniel Piñeiro(Hospital de Clínicas), Antoni Martínez‐Rubio(Universitat Autònoma de Barcelona), David Sim(Inserm), Roberto Colque(Fundacion Allende)
Cited by 115
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
|Circulation|2014|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k